La cadena de opciones muestra datos clave de las opciones de acciones de MBX Biosciences a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para MBX Biosciences..

MBX Biosciences (NASDAQ:MBX) Bolsa, Cadena de Opciones

MBX Biosciences

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ALUR

ASST

AVBP

CNOB

DWTX

HSTM

IPHA

LGTY

MDXG

The Marygold Companies, Inc. Common Stock

MGLD

MULN

ONCO

PXLW

RMBI

TVGN

VINC

Explora los movimientos más destacados del pre-mercado, incluyendo el aumento del 23% en Logility y más sorpresas.

Acciones de Logility Supply Chain (LGTY) suben un 23%; 20 acciones que se mueven en el premercado de EE.UU.

APLD

AZTR

CRKN

CVGW

GCTK

GLAC

HSDT

LFWD

MASS

ORKA

QBTS

QUBT

RIME

SGBX

VMAR

VRME

Descubre las acciones ganadoras y perdedoras en el premercado, con Vision Marine liderando un aumento del 45%.

Las acciones de Vision Marine (VMAR) se disparan un 45%; 20 acciones que se están moviendo en premercado

MBX Biosciences Inc

MICROBIX BIOSYSTEMS INC by Microbix Biosystems Inc.

Microbix Biosystems Inc

Susquehanna analyst Joseph Stauff initiates coverage on TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) with a Positive rating and announces Price Target of $180.

Price Target

Initiation

Analyst Ratings

Susquehanna Initiates Coverage On TKO Group Holdings with Positive Rating, Announces Price Target of $180

Barclays analyst Seth Sigman maintains O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) with a Equal-Weight and raises the price target from $1250 to $1290.

ORLY

Barclays Maintains Equal-Weight on O'Reilly Automotive, Raises Price Target to $1290

Wedbush analyst Alicia Reese maintains Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Outperform and lowers the price target from $125 to $100.

ROKU

Wedbush Maintains Outperform on Roku, Lowers Price Target to $100

Barclays analyst Lauren Lieberman maintains Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) with a Overweight and raises the price target from $37 to $38.

Barclays Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $38

Q4 and 2024 Year-End Preliminary Unaudited Select Financial Results
<ul>
<li>Expected $72.3 million in cash &amp; cash equivalents and short-term investments as of December 31, 2024 (inclusive of a $18 million credit facility) compared to $85.6 million in cash &amp; cash equivalents and short-term investments as of December 31, 2023 (inclusive of a $15 million credit facility).</li>
<li>Expected U.S. Generally Accepted Accounting Principles (GAAP) net loss in 2024 of $111.8 million, or $7.01 loss per share, compared to $114.2 million, $11.32 loss per share, in 2023.</li>
<li>Expected fourth quarter 2024 GAAP net loss of $37.3 million, or $1.51 loss per share, compared to $38.5 million, or $2.56 loss per share, in Q3 2024 and $35.2 million, or $3.44 loss per share, in Q4 2023. &nbsp;</li>
</ul>
The preliminary results presented reflect the Company's estimates based solely upon information available, and the Company's final results could differ from these estimates due to the completion of the Company's financial closing procedures, final adjustments and other developments that may arise between now and the time such audited consolidated financial statements for the year ended December 31, 2024 are issued. The Company expects to release the fully audited 2024 financial statements on or before May 15, 2025.

Earnings

Guidance

REE Automotive Provides 2024 Business Update; Reschedules The Release Date Of Its Q4 And FY24 Financial Results To Before The Market Opens On Thursday, May 15, 2025; Sees Q4 EPS $(1.51) Up From $(3.44) YoY

Barclays analyst David Anderson maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Overweight and lowers the price target from $265 to $230.

Barclays Maintains Overweight on Fiserv, Lowers Price Target to $230

Wedbush analyst Robert Driscoll reiterates Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Outperform and maintains $67 price target.

Reiteration

RVMD

Wedbush Reiterates Outperform on Revolution Medicines, Maintains $67 Price Target

Barclays analyst Michael Leithead maintains Element Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) with a Overweight and lowers the price target from $30 to $27.

Barclays Maintains Overweight on Element Solutions, Lowers Price Target to $27

Susquehanna analyst Joseph Stauff initiates coverage on Sphere Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) with a Positive rating and announces Price Target of $37.

SPHR

Susquehanna Initiates Coverage On Sphere Entertainment with Positive Rating, Announces Price Target of $37

A widespread power outage struck large parts of Spain and Portugal on Monday, disrupting daily life and causing travel chaos. Major cities including Madrid, Barcelona, Lisbon and Seville were affected, with reports of outages also emerging from parts <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45034627/us-stock-futures-fall-as-markets-brace-for-earnings-from-microsoft-meta-apple-and-apple-this-week-earnings-estimates-dont-signal-a-recession-says-leading-analyst">of France and Andorra.&nbsp;</a>
The Details: The blackout shut down traffic lights, caused heavy congestion on roads, and halted operations at airports, train stations, and metro systems. 
Read Next: <a href="https://www.benzinga.com/25/04/45012792/trump-administration-to-resume-collections-on-student-loans-5-million-borrowers-in-default?utm_source=articleShare">Trump Administration To Resume Collections On Student Loans: 5 Million Borrowers In Default&nbsp;</a>
In Madrid, traffic reached a standstill after signals failed, prompting police to advise people to avoid unnecessary travel and drive cautiously. The Madrid Open tennis tournament was suspended and fans exited in the dark. At Lisbon's Humberto Delgado Airport, travelers waited in unlit terminals without air conditioning or running water, and shops only accepted cash.
Spain's national rail operator, Renfe, reported that the blackout stopped trains nationwide and led to canceled departures. Metro systems in Madrid, Barcelona, and Valencia were also evacuated or shut down.
Portugal's grid operator, Redes Energéticas Nacionais, confirmed that the entire Iberian Peninsula lost electrical supply and some regions in France were also impacted. E-Redes, which manages electricity distribution in Portugal, described the incident as part of a broader European problem and began restoring connections in phases.
Spanish grid operator Red Electrica said it was working closely with energy companies to restore power. It stressed that the cause was under investigation and that all resources were being dedicated to resolving the issue. 
Early reports suggest the outage may have originated from a failure in a high-voltage interconnector in France, possibly linked to a fire that damaged a crucial power line. This disconnected the Iberian Peninsula from the European grid and triggered cascading failures. However, investigations are ongoing, and officials have not ruled out other causes, including cyberattacks.
Power restoration is underway, but authorities warn it may take hours or longer. That&#8217;s due to the complexity of restarting the grid after such a large-scale blackout. 
Markets React: European markets traded higher on Monday, with all sectors in positive territory despite the power outages. The Vanguard FTSE European ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGK#NYSE">VGK</a>) was up 0.08% in premarket trading in New York. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44952117/apple-and-meta-fined-nearly-800-million-for-violating-european-unions-digital-markets-act?utm_source=articleShare">Apple And Meta Fined Nearly $800 Million For Violating European Union&#8217;s Digital Markets Act</a>&nbsp;</li>
</ul>
Photo: Shutterstock

Specialty ETFs

Eurozone

Global

ETFs

Massive Power Outages Hit Spain, Portugal Snarling Travel: Investigations Into Cause Underway

Barclays analyst Kannan Venkateshwar maintains Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) with a Equal-Weight and lowers the price target from $37 to $35.

CMCSA

Barclays Maintains Equal-Weight on Comcast, Lowers Price Target to $35

<a href="https://www.autonews.com/canada/anc-tesla-canada-pricing-increase-over-tariffs/">https://www.autonews.com/canada/anc-tesla-canada-pricing-increase-over-tariffs/</a>
<a href="https://autonews.com/tesla">Tesla</a> is raising prices in Canada and encouraging buyers to snap up cars that were imported before counter-tariffs were imposed on U.S.-made vehicles.

Macro Economic Events

Politics

Economics

General

TSLA

'Tesla Hikes Canadian Prices And Pushes Its Pre-Tariff Inventory' - Automotive News

Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) announced Monday it has signed a deal for a secured debt facility and has achieved key operational and financial milestones that support its path toward profitability and <a href="https://www.benzinga.com/pressreleases/25/04/g45035933/plug-power-signs-525-million-secured-credit-facility-with-yorkville-advisors-and-reports-strong-pr" target="_blank" rel="noreferrer noopener">long-term growth</a>. The stock price gained after the update.
Plug has inked a deal for a secured debt facility with Yorkville Advisors that will allow the issuance of up to $525 million of secured debentures.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/44902049/plug-power-stock-sinks-40-in-april-amid-financial-struggles-despite-hydrogen-plant-launch" rel="noreferrer noopener">Plug Power Stock Sinks 40% In April Amid Financial Struggles Despite Hydrogen Plant Launch</a>
The facility includes an initial $210 million tranche, which will be fully funded at the initial closing, as well as additional tranches of up to $315 million. The initial tranche will likely close by May 2, 2025.
With the net proceeds from the initial tranche, Plug intends to use approximately $82.5 million to retire the majority of its existing convertible debenture principal outstanding with Yorkville.
Plug will report its first-quarter 2025 results in early May. Plug expects to report revenue of approximately $130 million to $134 million for the first quarter of 2025, compared to the analyst consensus of $131.61 million. Plug expects second-quarter revenue of $140 million to $180 million, versus the analyst consensus of $160.20 million.
Plug expects first-quarter net cash usage of approximately $142 million compared to $268 million a year ago. The company ended March 31, 2025, with approximately $296 million in unrestricted cash.
Plug completed construction of its new 15 TPD hydrogen production plant in St. Gabriel, Louisiana. Operated through the Hidrogenii joint venture with Olin Corporation, this facility strengthens Plug&#8217;s vertically integrated hydrogen network and will serve anchor customers, including Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>).
Plug has taken decisive actions to reduce its operational cost base, implementing changes in the first quarter that will likely drive over $200 million in incremental annualized run-rate savings. These cost-cutting measures, which have been largely completed, include organizational realignment and a company-wide focus on manufacturing and supply chain efficiency. The full impact of these cost savings will begin to be reflected in the coming quarters.
Plug Power stock has plunged over 65% year-to-date <a href="https://www.benzinga.com/quote/PLUG/analyst-ratings" target="_blank" rel="noreferrer noopener">after analysts cut</a> their price targets for the stock, as it failed to meet its quarterly revenue and EPS consensus.
Price Action: PLUG stock is up 12.0% at $0.9056 premarket at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44757588/lucid-wins-nikola-bankruptcy-auction-buys-nikola-facilities-for-30-million-to-boost-us-ev-production" target="_blank" rel="noreferrer noopener">Lucid Wins Nikola Bankruptcy Auction, Buys Nikola Facilities for $30 Million To Boost US EV Production</a></li>
</ul>
Photo: Shutterstock

AMZN

PLUG

Plug Power Rallies As New Financing, Cost Cuts Boost Confidence In Turnaround Plan

Government

Legal

STLA

Watching Shares Of Domestic Automakers; Reuters Reports Letter Sent By Major Automakers Urging Congress To Block California's Plan To End Sales Of Gas-Only Vehicles By 2035

Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) shares got a slight bump in early trading Monday. The company announced the termination of a 2018 consent order from the <a href="https://www.benzinga.com/pressreleases/25/04/b45036401/wells-fargo-confirms-termination-of-2018-cfpb-compliance-consent-order">Consumer Financial Protection Bureau (CFPB)</a>.
What Happened: Wells Fargo on Monday confirmed that the CFPB&#8217;s consent order related to the company&#8217;s risk management program has been terminated, representing the twelfth consent order closed by Wells Fargo regulators since 2019. 
&#8220;Today&#8217;s termination, along with the recent closure of other consent orders, demonstrates that we have completed much of our common risk and control infrastructure work, including work that is required by other orders,&#8221; said Charlie Scharf, CEO of Wells Fargo.
&#8220;I am proud of the work done by our teams and remain confident that we will complete the work needed to close our other open consent orders. Wells Fargo is a different and stronger company today as we focus on creating long-term value for our customers, clients, communities and shareholders.&#8221;
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/45035728/5-stocks-in-the-spotlight-last-week-wall-streets-most-accurate-analysts-weigh-in">5 Stocks In The Spotlight Last Week: Wall Street&#8217;s Most Accurate Analysts Weigh In</a>
<h3 class="wp-block-heading">How To Buy WFC Stock</h3>
By now you're likely curious about how to participate in the market for Wells Fargo &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Wells Fargo, which is trading at $69.73 as of publishing time, $100 would buy you 1.43 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
WFC Price Action: <a href="http://benzinga.com/quote/WFC">Wells Fargo shares</a> were up 0.32% at $69.95 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Bumble Dee/Shutterstock.

What's Going On With Wells Fargo Stock Today?

Barclays analyst Andrew Mok maintains Centene (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) with a Overweight and lowers the price target from $93 to $84.

Barclays Maintains Overweight on Centene, Lowers Price Target to $84

Good Morning Traders! In today&#8217;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#8217;s pulse to optimize your trading gains. Now, let&#8217;s dive into the stock analysis:
SPDR S&amp;P 500 ETF Trust (SPY)
SPY is currently trading near our pivot point at 549.67. Bulls are aiming to initiate a climb towards the next upside level at 550.45. Sustained bullish momentum above this area would then open the path to our next reference at 551.33. Holding steadily above 551.33 through regular trading could encourage further upside to 552.50, with the ultimate bullish objective today set at 553.66.
Conversely, if 549.67 fails to maintain support, sellers are expected to target 549.00 initially. Increased bearish activity could then lead to a deeper probe down to 548.13. Should selling accelerate aggressively past 548.13, we expect a firm test of support at 547.56. In a highly bearish scenario, the lower boundary for SPY today is projected at 546.46.
Invesco QQQ Trust Series 1 (QQQ)
The QQQ is trading around our critical point of 471.33. Bulls must actively defend this mark and demonstrate enough strength to push upward, first to 474.66. Solidifying above 474.66 would enhance bullish conviction and potentially drive prices up to 476.85. Robust buyer activity throughout the session could extend this advance towards 479.03, with our top bullish expectation today at 481.73.
On the downside, if the market struggles around 471.33, sellers are likely to seize the opportunity, initially targeting 469.27. Further weakness could encourage bears to explore lower support around 467.60. Persistent selling pressure might bring into focus the next key downside level at 465.93. If this area is breached convincingly, the bearish scenario targets 463.56.
Apple Inc. (AAPL)
Apple is trading near our significant level at 209.81. Bulls aim to secure this level early and then propel the price upward toward the next resistance at 211.12. Continued bullish activity could push Apple shares even higher to the level at 212.44. Sustained buying strength could then lead Apple to test the upper bullish target for today at 214.07.
Should support at 209.81 fail to hold during the trading session, sellers would likely test the lower boundary at 208.81. A continued bearish move could pressure the price further down to 207.93. Sustained selling could extend downward pressure towards 207.18, with a breakdown possibly leading Apple to our lowest bearish target of 206.55.
Microsoft Corp. (MSFT)
Microsoft shares are hovering close to our central pivot at 390.98. Bulls seek a definitive move above 392.49 to solidify buying momentum and challenge the next upside target at 393.47. A successful retest of 393.47 as reliable support could encourage bullish traders to pursue higher levels, starting with 394.46. Continued strong buying would ultimately target today&#8217;s bullish high at 395.68.
If support at 390.98 weakens significantly, bearish traders are expected to first test downside levels near 389.29. Breaking below this initial support would set up another downward move toward 388.53. Continued bearish momentum may push the price lower to 387.60. If bearish sentiment dominates, Microsoft&#8217;s lowest bearish target today is projected at 386.09.
NVIDIA Corporation (NVDA)
NVIDIA&#8217;s price is currently near our essential pivot point at 109.12. Bulls are targeting an upward push toward 109.86 and ideally converting this level into reliable intraday support. Strong buyer conviction could then drive the price higher to the next resistance at 110.73. With sustained bullish activity, the price could climb towards 111.70, ultimately aiming for today&#8217;s upper bullish target at 112.54.
On the downside, if support at 109.12 fails decisively, bearish traders will initially focus on lower levels near 107.51. Should sellers persist aggressively, the price could quickly drop to 106.30. A continued bearish scenario would further test downside strength at 105.23, with the lowest bearish objective today positioned at 103.96.
Alphabet Inc Class A (GOOGL)
Alphabet shares are trading close to our identified pivot at 161.79. Bulls must maintain stability here to build positive momentum and target the next level upward at 163.79. Continued bullish action could allow buyers to reach our top bullish objective today at 165.41.
Should 161.79 weaken during the trading session, bears would aim to drive the price down initially toward 160.36. Additional bearish pressure could prompt sellers to test lower supports at 158.54. In the event of heavy selling momentum, Alphabet shares may move sharply lower to today&#8217;s ultimate bearish level at 157.41.
Meta Platforms Inc (META)
Meta shares are trading around our pivot at 553.05. Bulls must maintain control above this price to target higher levels, beginning with a move toward 559.29. Continued strong buying could then push the market upward to 565.53. If bullish momentum remains persistent, we anticipate a rally toward our high bullish objective today at 573.25.
If support at 553.05 collapses during the session, bearish traders are expected to target an immediate decline toward 548.44. Continued selling pressure might accelerate downward to 541.79. Should the bearish scenario intensify further, Meta shares could approach today&#8217;s lowest bearish target at 537.68.
Tesla Inc. (TSLA)
Tesla shares are currently trading near our key pivot at 288.80. Bulls will seek immediate upside momentum, first targeting resistance at 290.47. Continued bullish activity could further propel the price upward toward our important reference at 293.21. A sustained bullish market move could then extend toward 294.60, with today&#8217;s upper bullish limit positioned at 296.44.
Conversely, if 288.80 breaks down, we anticipate bears targeting lower supports at 286.34. Persistent selling could lead to additional downward pressure toward 283.95. In the case of increased bearish sentiment, Tesla&#8217;s lowest bearish target today is at 281.32.
Final Word:&nbsp;
Today's economic calendar is notably sparse, with just two significant data releases. At 10:30 AM ET, market participants will receive the Dallas Fed Manufacturing Activity index for April, providing insight into regional economic trends. Additionally, at 11:30 AM ET, the Treasury will conduct its auction of 3-month and 6-month bills, potentially influencing short-term rates.
Given the minimal economic data, market attention will largely shift toward strategic positioning ahead of more impactful releases later this week, notably the JOLTS and NFP reports. Traders should also remain vigilant for news developments, especially concerning trade tariffs and ongoing international trade tensions, which could inject volatility into today&#8217;s market session. Stay focused, manage risks carefully, and have a profitable trading day!
The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.
Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day—hours before it&#8217;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.

Equities

Broad U.S. Equity ETFs

Technicals

Opinion

Signals

Technical Analysis For Trading SPY And Top Tech Stocks

Susquehanna analyst Joseph Stauff initiates coverage on Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) with a Positive rating and announces Price Target of $254.

MSGS

Susquehanna Initiates Coverage On Madison Square Garden with Positive Rating, Announces Price Target of $254

Barclays analyst George Wang maintains Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Overweight and lowers the price target from $157 to $126.

Barclays Maintains Overweight on Celestica, Lowers Price Target to $126

NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares are trading lower Monday. Reports from the weekend indicated that China&#8217;s Huawei Technologies has developed an AI chip to <a href="https://www.benzinga.com/markets/equities/25/04/45033025/nvidia-faces-new-challenge-as-huawei-tests-powerful-ascend-910d-ai-chip-amid-us-sanctions-aiming-to-disrupt-high-end-market-report">directly challenge Nvidia</a>. 
What To Know: Huawei has developed a new AI processor called Ascend 910D that it hopes will be a replacement for some higher-end chips made by Nvidia, the Wall Street Journal <a href="https://www.wsj.com/tech/chinas-huawei-develops-new-ai-chip-seeking-to-match-nvidia-8166f606">reported</a> on Sunday. 
People familiar with the matter said Huawei already approached some Chinese technology companies with intentions of testing the technical practicability of the new chip. 
Development of the chip is still in the early stages, but the company could reportedly receive its first sample batches by late May. This latest version of the company&#8217;s Ascend AI processor is expected to be more powerful than Nvidia's H100.
The news comes after Nvidia said in a regulatory filing earlier this month that the U.S. government informed the company that it will <a href="https://www.benzinga.com/news/global/25/04/44828742/nvidia-stock-is-tumbling-after-hours-heres-why">need a license</a> to export&nbsp;certain chips to China, focused on the company&#8217;s H20 chips.
A license will also be required for any other circuits achieving the H20&#8217;s memory bandwidth, interconnect bandwidth, or a combination thereof, Nvidia said in the filing.
Check This Out: <a href="https://in.benzinga.com/25/04/45030669/chamath-palihapitiya-says-nvidia-is-huaweis-new-target-a-national-champion-that-crushed-tech-giants-with-a-low-end-disruptor-strategy">Chamath Palihapitiya Says Nvidia Is Huawei&#8217;s &#8216;New Target&#8217; — A &#8216;National Champion&#8217; That Crushed Tech Giants With A &#8216;Low-End Disruptor&#8217; Strategy</a>
As a result of the restrictions, Nvidia said it expects its first-quarter financial results to include up to $5.5 billion of charges associated with H20 products held in inventory. Nvidia&#8217;s fiscal first quarter ended on Sunday and the company is due to report financial results for the period next month.
Analysts currently expect the chipmaker to report earnings of 88 cents per share and revenue of $43.09 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Huawei&#8217;s new chip is the latest version of its Ascend processor, with previous versions being called 910B and 910C. The report indicates that the Chinese chipmaker is expected to ship more than 800,000 Ascend 910B and 910C chips to customers this year. Some buyers are also reportedly in talks to increase orders following the chip restrictions from the Trump administration. 
NVDA Price Action: <a href="http://benzinga.com/quote/nvda">Nvidia shares</a> were down 0.96% at $109.94 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/04/45014765/if-you-invested-10k-in-nvidia-stock-10-years-ago-how-much-would-you-have-now">If You Invested $10K In Nvidia Stock 10 Years Ago, How Much Would You Have Now?</a></li>
</ul>
Photo: Hepha1st0s/Shutterstock.

NVDA

Nvidia Stock Is Sliding Monday Morning: What's Going On?

Press Releases

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

Health Care

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

MBX Biosciences to Participate in Upcoming February Investor Conferences

MBX Biosciences to Participate in March Investor Conferences

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism

MBX Biosciences Announces Additions to Leadership Team

MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference

Management

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

Comments

MBX Biosciences

MBX Biosciences (MBX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL